{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:11:09Z","timestamp":1759342269238},"reference-count":16,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1620\/tjem.236.289","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T22:02:56Z","timestamp":1438725776000},"page":"289-295","source":"Crossref","is-referenced-by-count":49,"title":["Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman\u2019s Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2"],"prefix":"10.1620","volume":"236","author":[{"given":"Yoshinobu","family":"Konishi","sequence":"first","affiliation":[{"name":"Department of Hematology, Osaka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Osaka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Nishi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Osaka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Sakamaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Osaka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Mitani","sequence":"additional","affiliation":[{"name":"Department of Hematology, Osaka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Hematology, Osaka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Mizutani","sequence":"additional","affiliation":[{"name":"Department of Hematology, Osaka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Ukyo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Osaka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Osaka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Tsudo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Osaka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Atkins, M.B. (2002) Interleukin-2: clinical applications. <i>Semin. Oncol.<\/i>, 29, 12-17.","DOI":"10.1053\/sonc.2002.33077"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Atkins, M.B., Lotze, M.T., Dutcher, J.P., Fisher, R.I., Weiss, G., Margolin, K., Abrams, J., Sznol, M., Parkinson, D., Hawkins, M., Paradise, C., Kunkel, L. &amp; Rosenberg, S.A. (1999) High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. <i>J. Clin. Oncol.<\/i>, 17, 2105-2016.","DOI":"10.1200\/JCO.1999.17.7.2105"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Castleman, B., Iverson, L. &amp; Menendez, V.P. (1956) Localized mediastinal lymphnode hyperplasia resembling thymoma. <i>Cancer<\/i>, 9, 822-830.","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Fajgenbaum, D.C., van Rhee, F. &amp; Nabel, C.S. (2014) HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. <i>Blood<\/i>, 123, 2924-2933.","DOI":"10.1182\/blood-2013-12-545087"},{"key":"5","unstructured":"Frizzera, G. (1988) Castleman\u2019s disease and related disorders. <i>Semin. Diagn. Pathol.<\/i>, 5, 346-364."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Frizzera, G., Banks, P.M., Massarelli, G. &amp; Rosai, J. (1983) A systemic lymphoproliferative disorder with morphologic features of Castleman\u2019s disease. Pathological findings in 15 patients. <i>Am. J. Surg. Pathol.<\/i>, 7, 211-231.","DOI":"10.1097\/00000478-198304000-00001"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Inoue, M., Ankou, M., Hua, J., Iwaki, Y., Hagihara, M. &amp; Ota, Y. (2013) Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporine A: a case report. <i>J. Clin. Exp. Hematop.<\/i>, 53, 95-99.","DOI":"10.3960\/jslrt.53.95"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Kawabata, H., Takai, K., Kojima, M., Nakamura, N., Aoki, S., Nakamura, S., Kinoshita, T. &amp; Masaki, Y. (2013) Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). <i>J. Clin. Exp. Hematop.<\/i>, 53, 57-61.","DOI":"10.3960\/jslrt.53.57"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Koduri, P.R., Parvez, M., Kaza, S., Pappu, P. &amp; Anuradha, S. (2014) Castleman-Kojima disease in a south Asian adolescent. <i>J. Clin. Exp. Hematop.<\/i>, 54, 163-166.","DOI":"10.3960\/jslrt.54.163"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Masaki, Y., Nakajima, A., Iwao, H., Kurose, N., Sato, T., Nakamura, T., Miki, M., Sakai, T., Kawanami, T., Sawaki, T., Fujita, Y., Tanaka, M., Fukushima, T., Okazaki, T. &amp; Umehara, H. (2013) Japanese variant of multicentric Castleman\u2019s disease associated with serositis and thrombocytopenia: a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity? <i>J. Clin. Exp. Hematop.<\/i>, 53, 79-85.","DOI":"10.3960\/jslrt.53.79"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Moutabarrik, A., Nakanishi, I., Takahara, S., Hachim, K., Bengahnem, M.G., Ramadani, B., Ishibashi, M. &amp; Zaid, D. (1994) Effect of immunosuppressive agents FK 506 and cyclosporin and steroids on the expression of IL-6 and its receptor by stimulated lymphocytes and monocytes. <i>Transpl. Int.<\/i>, 7, S552-S555.","DOI":"10.1111\/j.1432-2277.1994.tb01441.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Muskardin, T.W., Peterson, B.A. &amp; Molitor, J.A. (2012) Castleman disease and associated autoimmune disease. <i>Curr. Opin. Rheumatol.<\/i>, 24, 76-83.","DOI":"10.1097\/BOR.0b013e32834db525"},{"key":"13","doi-asserted-by":"crossref","unstructured":"O\u2019Keefe, S.J., Tamura, J., Kincaid, R.L., Tocci, M.J. &amp; O\u2019Neill, E.A. (1992) FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. <i>Nature<\/i>, 357, 692-694.","DOI":"10.1038\/357692a0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Petrella, T., Quirt, I., Verma, S., Haynes, A.E., Charette, M. &amp; Bak, K.; Melanoma Disease Site Group of Cancer Care Ontario\u2019s Program in Evidence-based Care (2007) Single-agent interleukin-2 in the treatment of metastatic melanoma: a systematic review. <i>Cancer Treat. Rev.<\/i>, 33, 484-496.","DOI":"10.1016\/j.ctrv.2007.04.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Rosenberg, S.A. (2014) IL-2: the first effective immunotherapy for human cancer. <i>J. Immunol.<\/i>, 192, 5451-5458.","DOI":"10.4049\/jimmunol.1490019"},{"key":"16","unstructured":"Takai, K., Nikkuni, K., Shibuya, H. &amp; Hashidate, H. (2010) Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. <i>Rinsho Ketsueki<\/i>, 51, 320-325."}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/236\/4\/236_289\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T17:00:23Z","timestamp":1498237223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/236\/4\/236_289\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.236.289","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}